Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDE10A | Q9Y233 | 2/20 | 0.35 |
| ▸ | CYP2E1 | P05181 | 2/20 | 0.34 |
| ▸ | CYP2A6 | P11509 | 2/20 | 0.34 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.34 |
| ▸ | GSR | P00390 | 1/20 | 0.34 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.33 |
| ▸ | METAP2 | P50579 | 3/20 | 0.33 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.33 |
| ▸ | CYP11B2 | P19099 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | PIK3CD | O00329 | 1/20 | 0.32 |
| ▸ | ELANE | P08246 | 1/20 | 0.32 |
| ▸ | MAT2A | P31153 | 5/20 | 0.31 |
| ▸ | PRMT5 | O14744 | 2/20 | 0.31 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9968126 | 0.80 | PDE10A (0.44) | PDE10ACYP3A4KMT2A | |
| SCHEMBL21453326 | 0.79 | CYP1A2 (0.41) | PDE10ACYP2E1CYP2A6CYP3A4CYP1A2 | |
| SCHEMBL23439034 | 0.70 | CYP1A2 (0.46) | CYP2E1CYP2A6CYP3A4GSRCYP1A2 | |
| SCHEMBL30578145 | 0.70 | CCR1 (0.55) | PDE10ACYP3A4METAP2 | |
| SCHEMBL17921511 | 0.70 | CCR1 (0.55) | PDE10ACYP3A4METAP2 | |
| SCHEMBL1611068 | 0.69 | CYP1A2 (0.46) | CYP2E1CYP2A6CYP3A4GSRCYP1A2 | |
| SCHEMBL21453320 | 0.69 | RORC (0.33) | PDE10ACYP3A4CYP1A2METAP2 | |
| SCHEMBL21008882 | 0.68 | EGLN1 (0.33) | PDE10ACYP2E1CYP2A6CYP3A4GSR | |
| SCHEMBL9968069 | 0.67 | PDE10A (0.34) | PDE10AKMT2A | |
| SCHEMBL16625781 | 0.67 | CYP1A2 (0.46) | CYP2E1CYP2A6CYP3A4GSRCYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20190312210-A1 | ORGANIC ELECTROLUMINESCENCE DEVICE AND POLYCYCLIC COMPOUND FOR ORGANIC ELECTROLUMINESCENCE DEVICE | SAMSUNG DISPLAY CO., LTD. (KR) | 2019-10-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190312210-A1 | ORGANIC ELECTROLUMINESCENCE DEVICE AND POLYCYCLIC COMPOUND FOR ORGANIC ELECTROLUMINESCENCE DEVICE | SLCO4C1, SLCO2A1, SLCO1A2 | PDE10A 3529/4885CYP2E1 332/4885CYP2A6 3277/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.